Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Guidance Tracker - January 2016

This article was originally published in SRA

Executive Summary

Click on the links to access the documents.

Country

 

Organization

 

Document

 

Status

 

International

 

AHWP

 

Regulation of Combination Products – a Review of International Practice

 

Final

 

International

 

AHWP

 

Guidance for Preparation of a Common Submission Dossier Template Dossier for General Medical Device Product Submission

 

Final

 

International

 

AHWP

 

Definition of the Terms "Medical Device" and "In Vitro Diagnostic (IVD) Medical Device"

 

Final

 

International

 

AHWP

 

Guidance Document on Qualification of Medical device Software

 

Final

 

International

 

AHWP

 

Adverse Event Reporting Guidance for the Medical Device Manufacturer or its Authorized Representative

 

Final

 

International

 

AHWP

 

Clinical Evaluation

 

Final

 

International

 

AHWP

 

Clinical Evidence for Medical Device – Key Definitions and Concepts

 

Final

 

International

 

AHWP

 

Clinical Evidence for IVD Medical Device – Key Definitions and Concept

 

Final

 

International

 

AHWP

 

Clinical Evidence for IVD Medical Device – Scientific Validity Determination and Performance Evaluation

 

Final

 

International

 

AHWP

 

Distributor Auditing Checklist

 

Final

 

International

 

AHWP

 

Guidance on Regulatory Auditing of Quality Management System of Medical Device Distributors: Auditing Strategies

 

Final

 

International

 

AHWP

 

Regulatory Audit Report Guidance Document

 

Final

 

International

 

AHWP

 

Guidance for Medical Device Naming Rule

 

Final

 

EU

 

EUnetHTA

 

HTA Core Model: Guiding principles on use

 

Final

 

Germany

 

BfArM

 

Guidance on "Medical Apps"

 

Final

 

Malaysia

 

MDA

 

Declaration of Conformity (DOC)

 

Final

 

US

 

FDA

 

Postmarket Management of Cybersecurity in Medical Devices

 

Draft

 

US

 

FDA

 

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices

 

Draft

 

US

 

FDA

 

List of Highest Priority Devices for Human Factors Review

 

Draft

 

US

 

FDA

 

Enforcement Policy on National Health Related Item Code and National Drug Code Numbers Assigned to Devices

 

Draft

 

US

 

FDA

 

Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile

 

Final

 

US

 

FDA

 

Applying Human Factors and Usability Engineering to Medical Devices

 

Final

 

You may also be interested in...



Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab

Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.

EU CHMP Opinions And MAA Updates

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

EMA Says Yes To 12 New Drugs Including Pfizer/AbbVie’s Antibiotic Combo

Emblaveo, for fighting infections caused by multidrug-resistant bacteria, is among the latest batch of medicines that the European Medicines Agency says should be approved for use in the EU.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel